Beyond the Clinic: Antimicrobial Peptides in Food, Agriculture, and Aquaculture
While therapeutic peptides capture headlines, the quietest revolution in the peptide field may be happening far from the clinic — in food processing facilities, agricultural fields, and aquaculture operations. Antimicrobial peptides (AMPs), nature’s own defense molecules, are being engineered for applications that could reshape how we preserve food and protect crops.
The Scale of the Opportunity
The global food preservative market is valued at $3.4 billion and growing at 4.1% annually. Traditional chemical preservatives (sodium benzoate, potassium sorbate, nitrites) face mounting consumer pressure and regulatory scrutiny. The European Food Safety Authority (EFSA) reauthorized only 8 of 23 synthetic preservatives in its 2024 review, creating a regulatory gap that natural alternatives can fill. AMPs are positioned to capture a significant share of this market.
Key Applications and Commercial Players
Food Preservation. Nisin, a 34-residue lantibiotic produced by Lactococcus lactis, has been used as a food preservative since 1969 and remains the gold standard. However, its narrow spectrum (primarily Gram-positive bacteria) has driven the search for broader-spectrum alternatives. Enterococcus-derived enterocins and engineered nisin variants with activity against Gram-negative pathogens including Listeria monocytogenes and Escherichia coli O157:H7 are in late-stage commercial development. Chr. Hansen (now Novonesis) launched an engineered nisin variant, Nisin Z+, in the European market in Q4 2025.
Crop Protection. AMPs offer an alternative to copper-based fungicides, which face phase-out in the EU under the Sustainable Use of Pesticides Regulation. Plant-expressed AMPs are being developed for citrus greening disease, potato late blight, and banana Fusarium wilt. A field trial of AMP-expressing oranges in Florida (2025) showed 73% reduction in infection, comparable to conventional antibiotic treatments but without the risk of antimicrobial resistance development in human pathogens.
Aquaculture. The global aquaculture industry loses an estimated $6 billion annually to bacterial infections. Norway’s salmon farming sector has committed to reducing antibiotic use by 99% by 2030. AMP-based feed additives and immersion treatments are emerging as the leading alternative. An AMP-supplemented salmon feed launched in January 2026 reported 41% lower mortality in Norwegian field trials.
Economics and Challenges
The cost of AMP synthesis remains the primary commercial barrier. Recombinant expression in yeast can produce AMPs at $50–200 per gram, competitive with premium synthetic preservatives but still 10–50× more expensive than bulk chemical alternatives. Solid-phase synthesis of longer AMPs pushes costs above $1,000 per gram. However, for high-value applications — organic produce, premium aquaculture, export-grade fruit — the economics already work. As production scales and enzymatic synthesis methods mature, the cost curve is expected to drop by 60–70% by 2030.